257 results match your criteria: "and Universitat Autonoma de Barcelona[Affiliation]"

Nowadays, synthetic cathinones (SCs) is the second more representative subclass of New Psychoactive Substances, accounting for 104 analogues in the illegal market. Since its first report in 2011, α-pyrrolidinovalerophenone (α-PVP) gained popularity among drug users, provoking an increased number of intoxications. Nonetheless, pharmacokinetics data is still limited in the literature.

View Article and Find Full Text PDF

Efficiency of telerehabilitation on subacute stroke ambulation: a matched case-control study.

Brain Impair

January 2025

Department of Research and Innovation, Institut Guttmann - Hospital de Neurorehabilitació, Institut Universitari de Neurorehabilitació adscrit a la UAB, Cami Can Ruti s/n, 08916, Badalona, Barcelona, Spain; and Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain; and Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Barcelona, Spain.

Article Synopsis
  • Stroke rehabilitation is increasingly needed worldwide, but there's limited evidence comparing telerehabilitation to in-person care.
  • A study found that patients with stroke who participated in telerehabilitation showed greater improvements in functional ambulation compared to those who received in-person rehabilitation.
  • Despite similar ambulation efficiency between the groups, telerehabilitation emerged as a promising alternative for individuals with moderate stroke severity, especially for those living with a partner at home.
View Article and Find Full Text PDF

Looking back to shape the future: Trajectories and resilience of social-ecological systems in the Global South.

Ambio

December 2024

Economics Research Institute, National Autonomous University of Mexico, Circuito Mario de la Cueva, Ciudad de la Investigación en Humanidades, C.P. 04510, Ciudad Universitaria, Mexico.

In complex Social-Ecological Systems (SES), the interplay between ecological and social components shapes trajectories that impact human well-being and ecosystem services. While SES dynamics have been studied in static conditions, there has been less attention to how said systems respond to shocks and stressors over time and space. This special issue presents a collection of articles that use diverse methodologies-ranging from system dynamics modeling to participatory approaches-to analyze past SES changes and discuss future scenarios.

View Article and Find Full Text PDF

Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study.

BMJ

August 2024

Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Article Synopsis
  • The study aimed to evaluate the effectiveness and potential clinical relevance of genome-targeted cancer drugs recommended by the National Comprehensive Cancer Network (NCCN) using established scales for actionability and clinical benefit.
  • A total of 411 drug recommendations were analyzed, with most being linked to clinical trials, particularly early-phase studies, but many did not provide strong evidence of substantial clinical benefit.
  • Only 12% of the evaluated trials demonstrated high clinical benefit (grades 4-5), while approximately 33% showed promise but were unproven, highlighting a need for more rigorous research in this area.
View Article and Find Full Text PDF

Background: Reports of allergic contact dermatitis (ACD) to phytonadione epoxide (PE) in cosmetics suggest that PE is as powerful a sensitiser as its parent compound phytonadione.

Objective: To evaluate a case series of ACD to PE in Spain.

Methods: We reviewed the records of 20 patients with ACD to cosmetics containing PE diagnosed across Spain between January 2019 and June 2023.

View Article and Find Full Text PDF

Myocardial remodelling, entailing cellular and molecular changes in the different components of the cardiac tissue in response to damage, underlies the morphological and structural changes leading to cardiac remodelling, which in turn contributes to cardiac dysfunction and disease progression. Since cardiac tissue is not available for histomolecular diagnosis, surrogate markers are needed for evaluating myocardial remodelling as part of the clinical management of patients with cardiac disease. In this setting, circulating biomarkers, a component of the liquid biopsy, provide a promising approach for the fast, affordable and scalable screening of large numbers of patients, allowing the detection of different pathological features related to myocardial remodelling, aiding in risk stratification and therapy monitoring.

View Article and Find Full Text PDF

Multidisciplinary care is essential for the management of patients with psoriatic disease (PsD), considering the great range of cutaneous and musculoskeletal symptoms and the potential for associated comorbidities and extraarticular manifestations. Consequently, combined rheumatology/dermatology clinics represent a gold standard model of care for patients with PsD. Many challenges are associated with the establishment of these clinics in routine clinical practice.

View Article and Find Full Text PDF

The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review.

Crit Rev Oncol Hematol

October 2024

Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1101 Hempstead Turnpike, Uniondale, NY 11553, USA. Electronic address:

Article Synopsis
  • The study investigates how prior treatments affect the effectiveness of new drugs for first-line metastatic breast cancer (MBC).
  • It analyzes data from FDA-approved MBC trials between 2000 and 2023, focusing on overall survival rates for treatment-naïve versus previously treated patients.
  • Results show no significant overall survival difference between the two groups, but treatment-naïve patients with triple-negative breast cancer experienced a notable survival benefit, suggesting a potential bias in evaluating new treatments.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness and tolerability of direct-acting antiviral (DAA) treatments for hepatitis C virus (HCV) across different genotypes (GTs) in a global, real-world context, focusing particularly on GT3 and GT6.
  • Researchers analyzed data from 15,849 chronic hepatitis C patients across Asia, North America, and Europe over a seven-year period, noting demographic factors such as age, sex, and prior treatment history.
  • Results showed a high sustained virological response (SVR12) rate of 96.9% overall, with variances by genotype, highlighting that independent factors like advanced age, cirrhosis, and previous treatment failures affected treatment outcomes, while being
View Article and Find Full Text PDF

Sex and ethnic disparities in hepatitis B evaluation and treatment across the world.

J Hepatol

July 2024

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, United States; Department of Epidemiology and Population Health, Stanford University School of Medicine, Palo Alto, California, United States. Electronic address:

Article Synopsis
  • Oral antiviral therapy for chronic hepatitis B (CHB) is effective and well-tolerated, but real-world data on how well patients are evaluated and treated is limited, prompting this study.
  • In a cross-sectional analysis of 12,566 adult patients from 25 centers across 9 countries, it was found that 73.3% received adequate evaluation, with only 32.6% of those deemed treatment-eligible actually starting antiviral therapy.
  • Factors influencing evaluation and treatment included gender, with females more likely to be evaluated but less likely to start treatment, and geographical differences, particularly among Asian patients from Western regions showing lower rates of evaluation and treatment.
View Article and Find Full Text PDF

Global cooperation and early access-clinical outcomes matter.

Lancet Oncol

June 2024

Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA.

View Article and Find Full Text PDF

Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies.

JAMA Oncol

May 2024

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Importance: The number of new genome-targeted cancer drugs has increased, offering the possibility of personalized therapy, often at a very high cost.

Objective: To assess the validity of molecular targets and therapeutic benefits of US Food and Drug Administration-approved genome-targeted cancer drugs based on the outcomes of their corresponding pivotal clinical trials.

Design And Settings: In this cohort study, all genome-targeted cancer drugs that were FDA-approved between January 1, 2015, and December 31, 2022, were analyzed.

View Article and Find Full Text PDF

Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies.

Clin Exp Rheumatol

February 2024

Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulations, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore; and Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Objectives: To assess nailfold video capillaroscopic (NVC) abnormalities and their association with clinical features, myositis-specific autoantibodies (MSA), and myositis-associated antibodies (MAA) in a large multi-ethnic cohort of patients with idiopathic inflammatory myopathies (IIM).

Methods: We recruited 155 IIM patients from three centres in Mexico, Spain, and the USA. We evaluated the clinical and laboratory features of the patients and performed semiquantitative and quantitative analyses of the NVC.

View Article and Find Full Text PDF

Forensic laboratories are constantly required to identify new drugs and their metabolites. N-ethylhexedrone (NEH, HEXEN), N-Ethylpentedrone (NEP), and 4-Chloromethcathinone (4-CMC, clephedrone) are synthetic substances structurally related to natural cathinone, alkaloid present in the leaves of the Catha edulis (Khat) plant. These synthetic cathinones (SC) are members of the heterogenous family of new psychoactive substances (NPS) that raised major concerns in scientific and forensic communities over the past years due to their widespread consumption.

View Article and Find Full Text PDF

Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review.

Cancer Treat Rev

January 2024

The Hebrew University Faculty of Medicine, Jerusalem, Israel; Oncology Institute, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address:

Background: As the treatment for metastatic breast cancer (MBC) often includes sequential lines of therapy, data on post-protocol treatment in clinical trials are valuable in the assessment of long-term outcomes. The objective of this study was to assess the reported data on post-protocol therapy in clinical trials supporting US Food and Drug Administration (FDA) approval of drugs for MBC.

Methods: All initial and subsequent publications related to FDA approved indications for MBC between January 2000 and February 2023 were identified.

View Article and Find Full Text PDF

Background: Wharton's Jelly (WJ) Mesenchymal Stromal Cells (MSC) have emerged as an attractive allogeneic therapy for a number of indications, except for bone-related conditions requiring new tissue formation. This may be explained by the apparent recalcitrance of MSC,WJ to differentiate into the osteogenic lineage in vitro, as opposed to permissive bone marrow (BM)-derived MSCs (MSC,BM) that readily commit to bone cells. Consequently, the actual osteogenic in vivo capacity of MSC,WJ is under discussion.

View Article and Find Full Text PDF

Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND).

Neurol Sci

March 2024

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy.

Background: Transition from child-centered to adult-centered healthcare is a gradual process that addresses the medical, psychological, and educational needs of young people in the management of their autonomy in making decisions about their health and their future clinical assistance. This transfer is challenging across all chronic diseases but can be particularly arduous in rare neurological conditions.

Aim: To describe the current practice on the transition process for young patients in centers participating in the European Reference Network for Rare Neurological Diseases (ERN-RND).

View Article and Find Full Text PDF
Article Synopsis
  • CHIR99021 is a GSK3β inhibitor showing potential for cardiomyocyte regeneration and treating hearing loss, but it has off-target effects on dopamine (DA) synthesis.
  • In experiments with rat brain striatum, CHIR99021 completely inhibited DA synthesis, unlike other inhibitors like SB216763 and lithium.
  • The inhibition appears linked to the reduction of tyrosine hydroxylase (TH) activity, which is crucial for dopamine production, suggesting implications for DA-related disorders and highlighting the need for further research into its mechanisms.
View Article and Find Full Text PDF

Allogeneic hematopoietic cell transplantation (allo-HCT) remains the sole curative option for myelofibrosis (MF). Relapse remains a significant problem, however, occurring in up to 20% to 30% of cases. Donor lymphocyte infusion (DLI) represents a potentially effective strategy for relapse prevention and management, but the optimal timing based on measurable residual disease/chimerism analyses and the choice of regimen remain undetermined.

View Article and Find Full Text PDF

Objectives: To assess the associations and prognostic value of scleroderma patterns by nailfold videocapillaroscopy (NVC) in patients with systemic sclerosis (SSc) and cutaneous subsets.

Methods: At baseline, 1356 SSc patients from the RESCLE registry were compared according to the scleroderma pattern as Late pattern and non-Late pattern, which included Early and Active patterns. Patient characteristics, disease features, survival time and causes of death were analysed.

View Article and Find Full Text PDF

Background: Cardiogenic shock (CGS) occurs in 10% of patients presenting with acute myocardial infarction (MI), with in-hospital mortality rates of 40-50% despite revascularisation.

Aims: The EURO SHOCK trial aimed to determine if early use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) could improve outcomes in patients with persistent CGS following primary percutaneous coronary intervention (PPCI).

Methods: This multicentre, pan-European trial randomised patients with persistent CGS 30 minutes after PPCI of the culprit lesion to receive either VA-ECMO or continue with standard therapy.

View Article and Find Full Text PDF

Introduction: Current guidelines discourage the use of direct-acting antiviral (DAA) containing protease-inhibitor (PI) in advanced HCV cirrhosis. We aimed to compare the real-world tolerability of PI vs. non-PI DAA regimens in this population.

View Article and Find Full Text PDF

Importance: Acute symptomatic seizures occurring within 7 days after ischemic stroke may be associated with an increased mortality and risk of epilepsy. It is unknown whether the type of acute symptomatic seizure influences this risk.

Objective: To compare mortality and risk of epilepsy following different types of acute symptomatic seizures.

View Article and Find Full Text PDF

The global Covid-19 pandemic has limited access to molecular TB diagnostics and National Programmes are struggling to maintain essential services. The pooling method (testing several samples together) could reduce the number of cartridges and staff time needed for TB diagnosis but has not been tested within the pandemic. We conducted two independent cross-sectional surveys.

View Article and Find Full Text PDF